These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 9506014)

  • 21. Endothelial cell activation and hypercoagulability in ocular Behçet's disease.
    Probst K; Fijnheer R; Rothova A
    Am J Ophthalmol; 2004 May; 137(5):850-7. PubMed ID: 15126149
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Search for anti-endothelial cell antibodies in patient with neuroimmunological disorders].
    Tanaka Y; Tsukada N; Koh CS; Yanagisawa N; Mochizuki I
    Arerugi; 1988 Dec; 37(12):1190-5. PubMed ID: 3248024
    [No Abstract]   [Full Text] [Related]  

  • 23. An update on Behçet's disease.
    Kalayciyan A; Zouboulis C
    J Eur Acad Dermatol Venereol; 2007 Jan; 21(1):1-10. PubMed ID: 17207160
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Caspase-9 expression is increased in endothelial cells of active Behçet's disease patients.
    Oztaş P; Lortlar N; Polat M; Alli N; Omeroğlu S; Basman A
    Int J Dermatol; 2007 Feb; 46(2):172-6. PubMed ID: 17269970
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Response to vaccination against hepatitis B in patients with Behcet's disease.
    Erkek E; Ayaslioglu E; Erkek AB; Kurtipek GS; Bagci Y
    J Gastroenterol Hepatol; 2005 Oct; 20(10):1508-11. PubMed ID: 16174066
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antibodies to endothelial cells in Behçet's disease: cell-binding heterogeneity and association with clinical activity.
    Cervera R; Navarro M; López-Soto A; Cid MC; Font J; Esparza J; Reverter JC; Monteagudo J; Ingelmo M; Urbano-Márquez A
    Ann Rheum Dis; 1994 Apr; 53(4):265-7. PubMed ID: 8203957
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Surgical treatment of Budd-Chiari syndrome induced by Behcet's disease.
    Kuniyoshi Y; Koja K; Miyagi K; Uezu T; Yamashiro S; Arakaki K; Mabuni K; Senaha S
    Ann Thorac Cardiovasc Surg; 2002 Dec; 8(6):374-80. PubMed ID: 12517299
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Renal involvement in Behçet's disease: review of 9 cases.
    El Ramahi KM; Al Dalaan A; Al Shaikh A; Al Meshari K; Akhtar M
    J Rheumatol; 1998 Nov; 25(11):2254-60. PubMed ID: 9818673
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Levels of soluble E-selectin in patients with active Behcet's disease.
    Sari RA; Kiziltunç A; Taysi S; Akdemir S; Gündoğdu M
    Clin Rheumatol; 2005 Feb; 24(1):55-9. PubMed ID: 15338451
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Mycoplasma antibody in Behçet's disease].
    Kunishi M
    Nihon Ganka Kiyo; 1967 Aug; 18(8):830-40. PubMed ID: 5626006
    [No Abstract]   [Full Text] [Related]  

  • 31. Mosaic of anti-endothelial antibodies. Review of the first international workshop on anti-endothelial antibodies: clinical and pathological significance Milan, 9 November 1994.
    Meroni PL; Khamashta MA; Youinou P; Shoenfeld Y
    Lupus; 1995 Apr; 4(2):95-9. PubMed ID: 7795630
    [No Abstract]   [Full Text] [Related]  

  • 32. Impaired endothelium-dependent flow-mediated dilation in Behçet's disease: more prominent endothelial dysfunction in patients with vascular involvement.
    Oflaz H; Mercanoglu F; Karaman O; Kamali S; Erer B; Genchellac H; Pamukcu B; Umman S; Inanc M; Gul A
    Int J Clin Pract; 2005 Jul; 59(7):777-81. PubMed ID: 15963203
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Is there a role for anti-phospholipid-binding protein antibodies in the pathogenesis of thrombosis in Behcet's disease?
    Priori R; Conti F; Pittoni V; Garofalo T; Sorice M; Valesini G
    Thromb Haemost; 2000 Jan; 83(1):173-4. PubMed ID: 10669174
    [No Abstract]   [Full Text] [Related]  

  • 34. Von Willebrand factor antigen levels in Behçet disease.
    Beyan E; Sadikoğlu B; Ertuğrul E; Beyan C
    Am J Hematol; 2005 May; 79(1):70-2. PubMed ID: 15849757
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Increased solubilization of immune complexes by the sera from patients with Behcet's disease.
    Tanaka K; Kajiyama K; Kameda S; Nishigouri S; Yamada I; Sawae Y
    Tohoku J Exp Med; 1983 Aug; 140(4):363-8. PubMed ID: 6636135
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Number VII Behçet's disease (Adamantiades syndrome).
    Escudier M; Bagan J; Scully C
    Oral Dis; 2006 Mar; 12(2):78-84. PubMed ID: 16476027
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Successful treatment of long-standing neuro-Behçet's disease with infliximab.
    Sarwar H; McGrath H; Espinoza LR
    J Rheumatol; 2005 Jan; 32(1):181-3. PubMed ID: 15630746
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Behçet's disease.
    Krause I; Weinberger A
    Curr Opin Rheumatol; 2008 Jan; 20(1):82-7. PubMed ID: 18281862
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Significance of serum interleukin-8 levels in patients with Behcet's disease: high levels may indicate vascular involvement.
    Durmazlar SP; Ulkar GB; Eskioglu F; Tatlican S; Mert A; Akgul A
    Int J Dermatol; 2009 Mar; 48(3):259-64. PubMed ID: 19261013
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Autoimmunity to S-antigen and retinal vasculitis in patients with Behçet's disease.
    Ermakova NA; Alekberova ZS; Prokaeva TB
    Adv Exp Med Biol; 2003; 528():279-81. PubMed ID: 12918707
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.